Both DNA-NE and DNA-MPO levels were significantly higher in patients with PsA colonization compared with those without (both P < 0.05; Fig. 3H), indicating that PsA drives NET elevation in patients with bronchiectasis. This evidence concerns the gene MPO and bronchiectasis.